Need to test impact of DNA-based risk scores
- Chris Griffiths1,
- Deesha Patel1,
- Ajiri Akporobaro1,
- Nyasha Chinyanganya2,
- Allan Hackshaw3,
- Clive Seale1,
- Robert Walton1,
- Stephen Spiro4
- 1Centre for Primary Care and Public Health, Blizard Institute, Queen Mary, University of London, London, UK
- 2Department of Thoracic Medicine, University College London Hospital NHS Foundation Trust, London, UK
- 3Cancer Research UK and University College London Cancer Trials Centre, London, UK
- 4Royal Brompton Hospital, London, UK
- Correspondence to Chris Griffiths, Centre for Primary Care and Public Health, Blizard Institute, Queen Mary, University of London, London, UK; c.j.griffiths{at}qmul.ac.uk
- Accepted 7 January 2012
- Published Online First 28 February 2012
- Asthma
- asthma guidelines
- asthma in primary care
- COPD mechanisms
- COPD epidemiology
- COPD exacerbations
- COPD pathology
- tuberculosis
- exercise
- asthma pharmacology
- paediatric lung disease
- tobacco and the lung
- lung cancer
- lung cancer chemotherapy
- non-small cell lung cancer
- small cell lung cancer
Young and Hopkins highlight the emerging data suggesting that smokers who perceive themselves at a lower risk of lung cancer may be less likely to take part in, and less likely to adhere to, lung cancer screening programmes.1–4 Their work suggesting that a risk score that …
